Nucleic Acid-Guided Nucleases Genome Editing Specificity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing nucleases for genome editing face challenges such as difficulties in large-scale purification, delivery issues due to size, and limitations in specificity, processivity, genome editing efficiency, and targeting functionality due to PAM recognition sequences.

Innovation Solution

Development of novel nucleic acid-guided nucleases with unique characteristics that enhance target recognition specificity and genetic editing efficiency, including engineered nuclease systems with guide polynucleotides designed to hybridize with specific target sequences in eukaryotic cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If existing nucleases are used for genome editing, then genome editing functionality is achieved, but purification on large scale becomes difficult

Engineering Contradiction:
Improvegenome editing efficiencyVSAvoidpurification difficulty
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The nuclease is divided into two separate components: a guide polynucleotide (crRNA or sgRNA) and a Cas protein. This segmentation allows the guide component to be easily synthesized and purified independently, while the Cas protein can be produced and purified separately, solving the purification difficulty while maintaining genome editing functionality.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The guide sequence is extracted as a separate functional element from the full-length CRISPR RNA, allowing it to be designed and synthesized independently. This extraction enables flexible combination with different Cas proteins and simplifies the purification process for both components.

Inventive Principle:
Principle #2Taking out (Extraction)

2Productivity

If existing nucleases are used for genome editing, then genome editing functionality is achieved, but delivery becomes challenging due to size

Engineering Contradiction:
Improvegenome editing efficiencyVSAvoiddelivery difficulty
Core Design Contradiction:
ProductivityVSEase of operation

Solution Approach 1:

The genome editing system is segmented into smaller components (guide polynucleotide and Cas protein) that can be delivered separately via different methods (e.g., RNA delivery, protein transduction, or separate plasmid transfection), overcoming the size limitations of delivering a single large nuclease complex.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system allows dynamic assembly of the nuclease complex inside the target cell after separate delivery of components, providing flexibility in delivery timing and method while achieving the same genome editing outcome.

Inventive Principle:
Principle #15Dynamics

3Reliability

If existing nucleases are used for genome editing, then basic editing capability is provided, but specificity and targeting functionality are limited

Engineering Contradiction:
Improvegenome editing specificityVSAvoidtargeting functionality
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The guide polynucleotide is designed with specific local sequences (20-nt spacer sequence) that provide high specificity for target recognition, while the Cas protein provides the catalytic function. This local quality differentiation enables high specificity without compromising versatility.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The Cas protein serves as a universal platform that can work with different guide polynucleotides targeting different genomic sequences. This multi-functionality allows a single Cas protein to provide versatile targeting capabilities across multiple genes and organisms while maintaining high specificity through guide sequence design.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The new genome editing tools provide increased flexibility and improved genome editing efficiency and specificity, making them suitable for various applications including biomedical research, agriculture, and human gene therapy.

Implementation Method 1

the guide sequence is designed to hybridize with a target sequence in a eukaryotic cell

Methodology Applied
Scientific EffectHybridization:

Data Source

PatentUS20250122490A1Nucleic Acid-Guided Nucleases
Publication Date: 2025.04.17 GIGAMUNE INC
  • US20250122490A1 patent drawing
  • US20250122490A1 patent drawing
  • US20250122490A1 patent drawing

AI summary

The present disclosure provides novel nucleic acid-guided nucleases and methods of using the nucleases for genome editing. The present disclosure further provides a system for editing a target region in a genome comprising a nucleic acid-guided nuclease, a heterologous guide nucleic acid for complexing with the nucleic acid-guided nuclease, and an editing polynucleotide configured to bind to the target region.